GET TO KNOW

 CYTOCHIP

.

Our story begins with a research project that enabled a portable device for testing blood cells of astronauts on space missions. Now as we apply our technology to needs on earth, we are positioned to transform in-vitro diagnostics, from hospitals to clinics, pharmacies and patient homes. Followed by a decade of research and development, CytoChip’s first test solution, the CitoCBC® system, is ready to launch. With a drop of blood, the CitoCBC® system provides a CBC comparable to central lab’s accuracy at the point of care within minutes.

THE

 CYTOCHIP ADVANTAGE

Reliability

We pride ourselves on the accuracy and reliability of results and are developing novel QC methods to ensure continued performance.  
Quick and Easy
We make testing to be quick and easy, unencumbered by operating space, storage condition, and personnel training.
Sustainable

We are driven to continuously lower cost and reduce waste to increase global access to testing.

OUR

 MISSION

.

Simplicity For Care

.

We strive to bring simplicity to diagnostics so that healthcare providers can deliver better care for their patients. We aim to extend accurate in-vitro diagnostics to places where healthcare can be easily accessible.

GET TO KNOW

 OUR TEAM

.

Our team is built to be nimble, reliable and sustainable, just like our products. We are scientists and engineers based in Irvine CA (Headquarter and Research Center) and Suzhou China (Engineering and Manufacturing Center). Together we seek a path that distinguishes us from the status quo.

WENDIAN SHI

  PhD

Founder / CEO

Wendian Shi has 10+ years R&D experiences in microfluidics and microfabrication, and the CytoChip technology origins from his PhD thesis at Caltech. Previously he is a microdevice engineer at 1Co Inc., leading the process development of an intraocular device for cataract surgery. Wendian received his PhD in Electrical Engineering from Caltech, and B.S. in Microelectronics from Peking University, China.

YU-CHONG TAI

  PhD

Cofounder /Technology advisor

Yu-Chong Tai is Anna L. Rosen Professor of Electrical Engineering and Mechanical Engineering, and Executive Office for Medical Engineering at Caltech. Dr. Tai works on miniature biomedical devices including drug pumps, intraocular lens, retinal implants, microfluidics and so on. Previously he cofounded several companies including MiniPumps LLC, Replenish Inc., and 1Co Inc. to bring university technologies to product.

Bob Roopra

  

Market Advisor

JANE F. EMERSON

  MD

Medical Advisor

Jane Emerson is Chief of Clinical Pathology at Department of Pathology, Medical Director of Clinical Laboratories, and Vice Chair of Clinical Programs at Department of Pathology and Laboratory Medicine, USC. Dr. Emerson has 20+ years experiences in clinical pathology and laboratory medicines, and previously consultanted for in-vitro diagnostics companies including Biomerica, Beckman Coulter, Hycor Biomedical, etc.

HISTORY

.

2015

Started the company in a garage;

Raised 1st round of investment

2016

Started R&D operation in L.A.

Won 1st place in Fosun Pharma’s Innostar Competition and others.

2017

Raised 2nd round of investment

Relocated headquarter to Irvine, CA

2019

Completed technology prototype;

2020

Started operation in Suzhou.

2021

Raised 3rd round of investment.

2022

Establish an Engineering Center in Suzhou, China.

2024

1st product obtained CE Mark.

2025

11st1 product obtained 510k clearance and granted CLIA Waived status by FDA.

Recognition by the Industry

.